Strategic partnerships FSHD Society actively collaborates with multiple innovation and research partners (Solve FSHD, FSHD Clinical Trial Research Network, Fulcrum Therapeutics) to accelerate treatment development and trial standardization, indicating fertile ground for co-funding, sponsorships, and joint program opportunities.

Clinical trial focus The organization is laser-focused on accelerating therapies and establishing standardized trial measures, presenting a strong demand for patient-centric trial recruitment services, data collection platforms, and biomarker development partnerships.

Global advocacy footprint As the world’s largest FSHD patient advocacy body with international initiatives like Walk & Roll, there is potential to offer event sponsorships, digital fundraising solutions, and broad-based awareness campaigns to expand donor engagement and corporate giving.

Tech and data readiness Current tech stack includes Salesforce, WordPress, analytics, and outreach tools, signaling readiness for integrated donor CRM enhancements, marketing automation, and analytics-driven fundraising services.

Funding and scale Operating with a 51-200 employee base and revenue in the low millions, the society represents a mid-sized philanthropic organization open to scalable solutions, sponsored programs, and consulting to optimize resource allocation and impact measurement.